This inventor holds 1 USPTO granted patent. Top assignee: Changchun Institute of Biological Products, Ministry of Public Health. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Innovations of Jingye Lu in Vaccine Development
Introduction
Jingye Lu is a prominent inventor based in Changchun, China. He has made significant contributions to the field of vaccine development, particularly in creating combined vaccines that enhance public health.
Latest Patents
Jingye Lu holds a patent for a combined vaccine against both hepatitis A virus (HAV) and measles virus. This innovative vaccine is designed to prevent infections from both diseases without causing any interference between the antigenicity of the two viruses. The patent details methods of producing the vaccine, including lyophilized formulations that offer enhanced storage stability. The combined live vaccine is a valuable tool for preventing hepatitis A and measles infections, ensuring safety and efficacy.
Career Highlights
Jingye Lu is affiliated with the Changchun Institute of Biological Products, which operates under the Ministry of Public Health. His work at this institution has been pivotal in advancing vaccine technology and improving public health outcomes.
Collaborations
Jingye Lu has collaborated with notable colleagues, including Pengfu Wang and Guangpu Li, to further enhance the research and development of vaccines.
Conclusion
Jingye Lu's contributions to vaccine innovation, particularly through his combined hepatitis A-measles vaccine, highlight his commitment to improving global health. His work continues to impact the field of immunization positively.